Table S1.
Correlation between GHRH-R expression and clinicopathological factors in GC patients
| GHRH-R expression | ||||
| Clinicopathological factors | No. of patients | Low GHRH-R, n (%) | High GHRH-R, n (%) | P value |
| Total | 106 | 56 (52.8) | 50 (47.2) | |
| Age (y) | ||||
| ≤60 | 54 | 29 (53.7) | 25 (46.3) | 0.527 |
| >60 | 52 | 27 (51.9) | 25 (48.1) | |
| Sex | ||||
| Female | 31 | 18 (58.1) | 13 (41.9) | 1.000 |
| Male | 75 | 38 (50.7) | 37 (49.3) | |
| Lauren classification | ||||
| Intestinal | 37 | 20 (54.1) | 17 (45.9) | 0.731 |
| Diffuse | 53 | 29 (54.7) | 24 (45.3) | |
| Mixed | 16 | 7 (43.8) | 9 (56.2) | |
| Tumor size | ||||
| ≤5 cm | 61 | 38 (62.3) | 23 (37.7) | 0.031 |
| >5 cm | 45 | 18 (40.0) | 27 (60.0) | |
| Differentiation | ||||
| Moderate-well | 43 | 23 (53.5) | 20 (46.5) | 1.000 |
| Poor | 63 | 33 (52.4) | 30 (47.6) | |
| pT status | ||||
| T1–T2 | 17 | 15 (88.2) | 2 (11.8) | 0.001 |
| T3–T4 | 89 | 41 (46.1) | 48 (53.9) | |
| pN status | ||||
| N0 | 28 | 16 (53.3) | 12 (46.7) | 0.662 |
| N1–N3 | 78 | 40 (51.3) | 38 (48.7) | |
| Distant metastasis | ||||
| M0 | 80 | 45 (56.2) | 35 (43.8) | 0.261 |
| M1 | 26 | 11 (42.3) | 15 (57.7) | |
| pTNM stage | ||||
| I–II | 22 | 16 (72.7) | 6 (27.3) | 0.054 |
| III–IV | 84 | 40 (47.6) | 44 (52.4) | |
pT, pathological tumor; pN, pathological nodal; pTNM, pathological tumor-node-metastasis.